New Products

Premium

Abbott Molecular has launched its CE-Marked Abbott HBV Sequencing test in the European Union. The test is the first sequencing-based diagnostic to be developed by Abbott, and was developed on Life Technologies' CE 3130 DNA sequencing system.

According to the company, the test identifies the DNA sequence of the hepatitis B virus polymerase gene, including all clinically relevant HBV drug resistant mutations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.